| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Biochemistry, Center in Molecular Toxicology, and the Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232
Defective cell cycle checkpoint function has been linked to enhanced sensitivity of tumor cells to certain genotoxic agents. To determine whether loss of the G1-S checkpoint function would sensitize tumor cells to microtubule inhibitor (MTI)-induced apoptosis, we examined the effect of the MTIs, Taxol and vincristine, on the cell cycle kinetics and survival of two isogenic cell lines, HCT116 p21+/+ and HCT116 p21-/-, which differ only at the p21 locus. p21-deficient cells displayed a dose-dependent, enhanced chemosensitivity to MTIs in both monolayer and soft agar assays as well as in mice xenograft tumors. The increased sensitivity of the p21-deficient cells to MTIs correlated with prolonged cyclin B1/Cdc2 activity and the occurrence of endoreduplication. Furthermore, sensitivity of p53-deficient cells to MTI-induced apoptosis was significantly reduced by induction of ectopic p21 protein. The results suggest that the status of G1-S checkpoint function in tumor cells may be an important determinant in the efficacy of MTIs used clinically.
This article has been cited by other articles:
|
|
 |
|
  C.-T. Chiang, T.-D. Way, and J.-K. Lin Sensitizing HER2-overexpressing cancer cells to luteolin-induced apoptosis through suppressing p21WAF1/CIP1 expression with rapamycin Mol. Cancer Ther., July 1, 2007; 6(7): 2127 - 2138. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Crescenzi, G. Palumbo, and H. J.M. Brady Roscovitine Modulates DNA Repair and Senescence: Implications for Combination Chemotherapy Clin. Cancer Res., November 15, 2005; 11(22): 8158 - 8171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Yu, P. J. Moos, P. Cassidy, M. Wade, and F. A. Fitzpatrick Conditional Expression of 15-Lipoxygenase-1 Inhibits the Selenoenzyme Thioredoxin Reductase: MODULATION OF SELENOPROTEINS BY LIPOXYGENASE ENZYMES J. Biol. Chem., July 2, 2004; 279(27): 28028 - 28035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Okada, C. Bakal, A. Shahinian, A. Elia, A. Wakeham, W.-K. Suh, G. S. Duncan, M. Ciofani, R. Rottapel, J. C. Zuniga-Pflucker, et al. Survivin Loss in Thymocytes Triggers p53-mediated Growth Arrest and p53-independent Cell Death J. Exp. Med., February 2, 2004; 199(3): 399 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fukuda, C. R. Mantel, and L. M. Pelus Survivin regulates hematopoietic progenitor cell proliferation through p21WAF1/Cip1-dependent and -independent pathways Blood, January 1, 2004; 103(1): 120 - 127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jung, M. Motwani, J. Kortmansky, F. M. Sirotnak, Y. She, M. Gonen, A. Haimovitz-Friedman, and G. K. Schwartz The Cyclin-Dependent Kinase Inhibitor Flavopiridol Potentiates {gamma}-Irradiation-Induced Apoptosis in Colon and Gastric Cancer Cells Clin. Cancer Res., December 1, 2003; 9(16): 6052 - 6061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Burns, P. Fei, K. A. Scata, D. T. Dicker, and W. S. El-Deiry Silencing of the Novel p53 Target Gene Snk/Plk2 Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed Cells Mol. Cell. Biol., August 15, 2003; 23(16): 5556 - 5571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fan, A. D. Borowsky, and R. H. Weiss An Antisense Oligodeoxynucleotide to p21Waf1/Cip1 Causes Apoptosis in Human Breast Cancer Cells Mol. Cancer Ther., August 1, 2003; 2(8): 773 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Gartel and A. L. Tyner The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis Mol. Cancer Ther., June 1, 2002; 1(8): 639 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kasai, Y. Iwanaga, H. Iha, and K.-T. Jeang Prevalent Loss of Mitotic Spindle Checkpoint in Adult T-cell Leukemia Confers Resistance to Microtubule Inhibitors J. Biol. Chem., February 8, 2002; 277(7): 5187 - 5193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Motwani, C. Jung, F. M. Sirotnak, Y. She, M. A. Shah, M. Gonen, and G. K. Schwartz Augmentation of Apoptosis and Tumor Regression by Flavopiridol in the Presence of CPT-11 in Hct116 Colon Cancer Monolayers and Xenografts Clin. Cancer Res., December 1, 2001; 7(12): 4209 - 4219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Blagosklonny and A. B. Pardee Exploiting Cancer Cell Cycling for Selective Protection of Normal Cells Cancer Res., June 1, 2001; 61(11): 4301 - 4305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Modestou, V. Puig-Antich, C. Korgaonkar, A. Eapen, and D. E. Quelle The Alternative Reading Frame Tumor Suppressor Inhibits Growth through p21-dependent and p21-independent Pathways Cancer Res., April 1, 2001; 61(7): 3145 - 3150. [Abstract] [Full Text]
|
|
|
|
|
|
P. Dent and S. Grant Pharmacologic Interruption of the Mitogen-activated Extracellular-regulated Kinase/Mitogen-activated Protein Kinase Signal Transduction Pathway: Potential Role in PromotingCytotoxic Drug Action Clin. Cancer Res., April 1, 2001; 7(4): 775 - 783. [Full Text]
|
|
|
|
|
|
P. A. Hershberger, W.-D. Yu, R. A. Modzelewski, R. M. Rueger, C. S. Johnson, and D. L. Trump Calcitriol (1,25-Dihydroxycholecalciferol) Enhances Paclitaxel Antitumor Activity in Vitro and in Vivo and Accelerates Paclitaxel-induced Apoptosis Clin. Cancer Res., April 1, 2001; 7(4): 1043 - 1051. [Abstract] [Full Text]
|
|
|
|
 |
|
 F. Yang, A. von Knethen, and B. Brüne Modulation of nitric oxide-evoked apoptosis by the p53-downstream target p21WAF1/CIP1 J. Leukoc. Biol., December 1, 2000; 68(6): 916 - 922. [Abstract] [Full Text]
|
|
|
|
|
|
W. F. Symmans, M. D. Volm, R. L. Shapiro, A. B. Perkins, A. Y. Kim, S. Demaria, H. T. Yee, H. McMullen, R. Oratz, P. Klein, et al. Paclitaxel-induced Apoptosis and Mitotic Arrest Assessed by Serial Fine-Needle Aspiration: Implications for Early Prediction of Breast Cancer Response to Neoadjuvant Treatment Clin. Cancer Res., December 1, 2000; 6(12): 4610 - 4617. [Abstract] [Full Text]
|
|
|
|
|
|
P. M. Flatt, L. J. Tang, C. D. Scatena, S. T. Szak, and J. A. Pietenpol p53 Regulation of G2 Checkpoint Is Retinoblastoma Protein Dependent Mol. Cell. Biol., June 15, 2000; 20(12): 4210 - 4223. [Abstract] [Full Text]
|
|
|
|
|
|
S. Adimoolam, C. X. Lin, and J. M. Ford The p53-regulated Cyclin-dependent Kinase Inhibitor, p21 (cip1, waf1, sdi1), Is Not Required for Global Genomic and Transcription-coupled Nucleotide Excision Repair of UV-induced DNA Photoproducts J. Biol. Chem., July 6, 2001; 276(28): 25813 - 25822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Saez, M. C. Nelson, B. Eshelman, E. Banayo, A. Koder, G. J. Cho, and R. M. Evans Identification of ligands and coligands for the ecdysone-regulated gene switch PNAS, December 19, 2000; 97(26): 14512 - 14517. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
